secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspira Women's Health Inc. (AWHL)
CIK:        0000926617
Form:       8-K
Filed at:   2022-02-28T23:59:59+00:00
Accession:  0001387131-22-002576
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aspira Women's Health appoints Sandford as CEO, Palmieri as Executive Chair
---------------------------------------------------------------------------

- Nicole Sandford appointed President and CEO effective March 1, 2022; base salary $500,000, one-year term.
- Valerie Palmieri transitions to Executive Chair effective March 1; base salary $450,000, one-year term.
- Celeste Fralick, Ph.D., appointed to Board effective Feb 23, 2022; will serve on Audit Committee.
- Bylaws amended to require lead director selection if Board chair is not an independent director.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/926617/000138713122002576/0001387131-22-002576-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/926617/000138713122002576/awh-8k_022322.htm
  HTML page:      https://secwatch.observer/filing/0001387131-22-002576

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer